SUMMARY
In 20% women in perimenopause occurs such the pathology of breast as fibrocystic breast disease.The aim of study was to investigate the effectiveness and impact of the normomens drug on dysmetabolic disorders in women during perimenopause and early menopause on the background of fibrocystic breast changes.There were 50 premenopausal women aged 43–48 years under supervision with dysmetabolic changes. Women were divided into two groups depending on condition and structure of mammary glands – 25 women with breast pathology as fibrocystic changes (group I), 25 women with no pathological changes in the mammary glands (group II).To correct dismetabolic disorders background fibrocystic breast changes the phytopreparation normomens was used for 6 months.The results showed a significant decrease in the psycho-emotional symptoms severity of climacteric syndrome, in some patients was restoration of regular menstrual periods, reduced the frequency and intensity of breast pain, women noted sleep improvement and a feeling of peace, comfort, weight reduction. In the breast after 3 months therapy in the dynamics ultrasound examination showed a decrease of the breast tissue density, after 6 months therapy it was reduction of the cysts diameter and number.Thus, the proposed complex therapy with phytopreparation normomens showed good effect (treatment efficacy amounted to 89.7% of cases) for correction of metabolic disorders, mental and emotional state, and structural changes in the mammary glands, proves multivalent effect of the drug and makes it possible to use it as an alternative to hormone replacement therapy in perimenopause and early menopause. Normomens use allows not only to the prevention of breast cancer, but also improves the comfort and quality of patients’ life during premenopause and early menopause.